235 related articles for article (PubMed ID: 29165684)
21. Ready for HIV Dual Therapy? - New Data from International HIV/AIDS Society 2017.
Yendewa GA; Salata RA
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019353
[TBL] [Abstract][Full Text] [Related]
22. Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.
Sereti I; Krebs SJ; Phanuphak N; Fletcher JL; Slike B; Pinyakorn S; O'Connell RJ; Rupert A; Chomont N; Valcour V; Kim JH; Robb ML; Michael NL; Douek DC; Ananworanich J; Utay NS;
Clin Infect Dis; 2017 Jan; 64(2):124-131. PubMed ID: 27737952
[TBL] [Abstract][Full Text] [Related]
23. Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy.
Ghura S; Gross R; Jordan-Sciutto K; Dubroff J; Schnoll R; Collman RG; Ashare RL
J Neuroimmune Pharmacol; 2020 Dec; 15(4):694-714. PubMed ID: 31834620
[TBL] [Abstract][Full Text] [Related]
24. HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System.
Nickoloff-Bybel EA; Calderon TM; Gaskill PJ; Berman JW
J Neuroimmune Pharmacol; 2020 Dec; 15(4):729-742. PubMed ID: 32506353
[TBL] [Abstract][Full Text] [Related]
25. Cognitive Impairment and Persistent CNS Injury in Treated HIV.
Chan P; Hellmuth J; Spudich S; Valcour V
Curr HIV/AIDS Rep; 2016 Aug; 13(4):209-17. PubMed ID: 27188299
[TBL] [Abstract][Full Text] [Related]
26. [Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)].
Iribarren JA; Labarga P; Rubio R; Berenguer J; Miró JM; Antela A; González J; Moreno S; Arrizabalaga J; Chamorro L; Clotet B; Gatell JM; López-Aldeguer J; Martínez E; Polo R; Tuset M; Viciana P; Santamaría JM; Kindelán JM; Ribera E; Segura F; ;
Enferm Infecc Microbiol Clin; 2004 Dec; 22(10):564-642. PubMed ID: 15596051
[TBL] [Abstract][Full Text] [Related]
27. Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial.
Longenecker CT; Hileman CO; Funderburg NT; McComsey GA
Clin Infect Dis; 2014 Oct; 59(8):1148-56. PubMed ID: 25015912
[TBL] [Abstract][Full Text] [Related]
28. Brief Report: Changes in Levels of Inflammation After Antiretroviral Treatment During Early HIV Infection in AIDS Clinical Trials Group Study A5217.
Macatangay BJ; Yang M; Sun X; Morton J; De Gruttola V; Little S; Hogan C; Rinaldo CR;
J Acquir Immune Defic Syndr; 2017 May; 75(1):137-141. PubMed ID: 28198712
[TBL] [Abstract][Full Text] [Related]
29. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL
AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445
[TBL] [Abstract][Full Text] [Related]
30. Increased IL-8 levels in HIV-infected individuals who initiated ART with CD4
Ellwanger JH; Valverde-Villegas JM; Kaminski VL; de Medeiros RM; Almeida SEM; Santos BR; de Melo MG; Hackenhaar FS; Chies JAB
Microbes Infect; 2020 Oct; 22(9):474-480. PubMed ID: 32534178
[TBL] [Abstract][Full Text] [Related]
31. Long-term Therapeutic Impact of the Timing of Antiretroviral Therapy in Patients Diagnosed With Primary Human Immunodeficiency Virus Type 1 Infection.
Novelli S; Lécuroux C; Avettand-Fenoel V; Seng R; Essat A; Morlat P; Viard JP; Rouzioux C; Meyer L; Goujard C
Clin Infect Dis; 2018 May; 66(10):1519-1527. PubMed ID: 29211834
[TBL] [Abstract][Full Text] [Related]
32. Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.
Gandhi RT; McMahon DK; Bosch RJ; Lalama CM; Cyktor JC; Macatangay BJ; Rinaldo CR; Riddler SA; Hogg E; Godfrey C; Collier AC; Eron JJ; Mellors JW;
PLoS Pathog; 2017 Apr; 13(4):e1006285. PubMed ID: 28426825
[TBL] [Abstract][Full Text] [Related]
33. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.
Boulware DR; Hullsiek KH; Puronen CE; Rupert A; Baker JV; French MA; Bohjanen PR; Novak RM; Neaton JD; Sereti I;
J Infect Dis; 2011 Jun; 203(11):1637-46. PubMed ID: 21592994
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
Henrich TJ; Hatano H; Bacon O; Hogan LE; Rutishauser R; Hill A; Kearney MF; Anderson EM; Buchbinder SP; Cohen SE; Abdel-Mohsen M; Pohlmeyer CW; Fromentin R; Hoh R; Liu AY; McCune JM; Spindler J; Metcalf-Pate K; Hobbs KS; Thanh C; Gibson EA; Kuritzkes DR; Siliciano RF; Price RW; Richman DD; Chomont N; Siliciano JD; Mellors JW; Yukl SA; Blankson JN; Liegler T; Deeks SG
PLoS Med; 2017 Nov; 14(11):e1002417. PubMed ID: 29112956
[TBL] [Abstract][Full Text] [Related]
35. Incomplete Antiretroviral Therapy Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV Infection in Mexico.
Belaunzarán-Zamudio PF; Naranjo L; Caro-Vega Y; Castillo-Mancilla JR; Camiro-Zuñiga A; Fuentes-García R; Crabtree-Ramírez BE; Sierra-Madero JG
AIDS Res Hum Retroviruses; 2023 Mar; 39(3):136-144. PubMed ID: 36597354
[TBL] [Abstract][Full Text] [Related]
36. Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.
Christensen-Quick A; Massanella M; Frick A; Rawlings SA; Spina C; Vargas-Meneses M; Schrier R; Nakazawa M; Anderson C; Gianella S
J Virol; 2019 Jul; 93(13):. PubMed ID: 31019052
[TBL] [Abstract][Full Text] [Related]
37. HIV and renal disease: a contemporary review.
Gameiro J; Jorge S; Lopes JA
Int J STD AIDS; 2018 Jun; 29(7):714-719. PubMed ID: 29343165
[TBL] [Abstract][Full Text] [Related]
38. Special considerations in the initiation and management of antiretroviral therapy in individuals coinfected with HIV and hepatitis C.
Braitstein P; Palepu A; Dieterich D; Benhamou Y; Montaner JS
AIDS; 2004 Nov; 18(17):2221-34. PubMed ID: 15577534
[TBL] [Abstract][Full Text] [Related]
39. What Will It Take to Cure HIV?
Ananworanich J
Top Antivir Med; 2015; 23(2):80-4. PubMed ID: 26200707
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.
Guha D; Mukerji SS; Chettimada S; Misra V; Lorenz DR; Morgello S; Gabuzda D
AIDS; 2019 Mar; 33(4):615-625. PubMed ID: 30557159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
